{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-015026","form_type":"8-K","ticker":"AUPH","cik":"0001600620","company_name":"Aurinia Pharmaceuticals Inc.","filed_at":"2022-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.390265+00:00","generated_at":"2026-06-25T08:42:55.751290+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Aurinia shareholders elect all nine board nominees and approve auditor and say-on-pay at 2022 annual meeting","bullets":["All nine director nominees elected; for votes ranged from 24.1M (Hagan) to 34.3M (Balakrishnan); broker non-votes 27.9M.","PricewaterhouseCoopers ratified as independent auditor: 63.3M for, 6.7M against, 2.0M abstain.","Say-on-pay advisory resolution approved: 33.1M for, 10.5M against, 0.6M abstain; 27.9M broker non-votes.","Meeting held virtually on May 17, 2022; results reported on May 20, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-015026","json":"https://secwatch.observer/filing/0001628280-22-015026.json","markdown":"https://secwatch.observer/filing/0001628280-22-015026.md","text":"https://secwatch.observer/filing/0001628280-22-015026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022015026/0001628280-22-015026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022015026/auph-20220517.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T08:42:55.751290+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}